{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:02:38Z","timestamp":1793116958477,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T00:00:00Z","timestamp":1577318400000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"China Postdoctoral Science Fund","award":["21510077311145"],"award-info":[{"award-number":["21510077311145"]}]},{"name":"China Postdoctoral Science Fund","award":["21300076311047"],"award-info":[{"award-number":["21300076311047"]}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2016HM27"],"award-info":[{"award-number":["ZR2016HM27"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Epithelial ovarian cancer (EOC) is the most lethal cancer in female genital tumors. New disease markers and novel therapeutic strategies are urgent to identify considering the current status of treatment. Receptor tyrosine kinases family plays critical roles in embryo development and disease progression. However, ambivalent research conclusions of ROR2 make its role in tumor confused and the underlying mechanism is far from being understood. In this study, we sought to clarify the effects of ROR2 on high-grade serous ovarian carcinoma (HGSOC) cells and reveal the mechanism.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Immunohistochemistry assay and western-blot assay were used to detect proteins expression. ROR2 overexpression adenovirus and Lentivirus were used to create ROR2 overexpression model in vitro and in vivo, respectively. MTT assay, colony formation assay and transwell assay were used to measure the proliferation, invasion and migration ability of cancer cells. Flow cytometry assay was used to detect cell apoptosis rate. Whole transcriptome analysis was used to explore the differentially expressed genes between ROR2 overexpression group and negative control group. SiRNA targeted IRE1\u03b1 was used to knockdown IRE1\u03b1. Kira6 was used to inhibit phosphorylation of IRE1\u03b1.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Expression of ROR2 was significantly lower in HGSOC tissues compared to normal fallopian tube epithelium or ovarian surface epithelium tissues. In HGSOC cohort, patients with advanced stages or positive lymph nodes were prone to express lower ROR2. Overexpression of ROR2 could repress the proliferation of HGSOC cells and induce cell apoptosis. RNA sequencing analysis indicated that ROR2 overexpression could induce unfold protein response. The results were also confirmed by upregulation of BIP and phosphorylated IRE1\u03b1. Furthermore, pro-death factors like CHOP, phosphorylated JNK and phosphorylated c-Jun were also upregulated. IRE1\u03b1 knockdown or Kira6 treatment could reverse the apoptosis induced by ROR2 overexpression. Finally, tumor xenograft experiment showed ROR2 overexpression could significantly repress the growth rate and volume of transplanted tumors.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Taken together, ROR2 downregulation was associated with HGSOC development and progression. ROR2 overexpression could repress cell proliferation and induce cell apoptosis in HGSOC cells. And the underlying mechanism might be the activation of IRE1\u03b1\/JNK\/CHOP pathway induced by ROR2.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12967-019-02178-x","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T16:02:24Z","timestamp":1577376144000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["ROR2 induces cell apoptosis via activating IRE1\u03b1\/JNK\/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo"],"prefix":"10.1186","volume":"17","author":[{"given":"Rui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanjuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangtao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongluan","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7397-7408","authenticated-orcid":false,"given":"Peishu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,26]]},"reference":[{"key":"2178_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68:284\u201396. https:\/\/doi.org\/10.3322\/caac.21456.","journal-title":"CA Cancer J Clin"},{"key":"2178_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ajog.2015.03.044","volume":"213","author":"FR Nezhat","year":"2015","unstructured":"Nezhat FR, Apostol R, Nezhat C, Pejovic T. New insights in the pathophysiology of ovarian cancer and implications for screening and prevention. Am J Obstet Gynecol. 2015;213:262\u20137. https:\/\/doi.org\/10.1016\/j.ajog.2015.03.044.","journal-title":"Am J Obstet Gynecol"},{"key":"2178_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/35077225","volume":"411","author":"P Blume-Jensen","year":"2001","unstructured":"Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature. 2001;411:355\u201365. https:\/\/doi.org\/10.1038\/35077225.","journal-title":"Nature"},{"key":"2178_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00018-002-8407-9","volume":"59","author":"WC Forrester","year":"2002","unstructured":"Forrester WC. The Ror receptor tyrosine kinase family. Cell Mol Life Sci. 2002;59:83\u201396.","journal-title":"Cell Mol Life Sci"},{"key":"2178_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1081\/RRS-120018757","volume":"23","author":"A Yoda","year":"2003","unstructured":"Yoda A, Oishi I, Minami Y. Expression and function of the Ror-family receptor tyrosine kinases during development: lessons from genetic analyses of nematodes, mice, and humans. J Recept Signal Transduct Res. 2003;23:1\u201315. https:\/\/doi.org\/10.1081\/RRS-120018757.","journal-title":"J Recept Signal Transduct Res"},{"key":"2178_CR6","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.1158\/0008-5472.CAN-12-3832","volume":"73","author":"B Cui","year":"2013","unstructured":"Cui B, Zhang S, Chen L, Yu J, Widhopf GF, Fecteau J-F, et al. Targeting ROR1 inhibits epithelial\u2013mesenchymal transition and metastasis. Cancer Res. 2013;73:3649\u201360. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-3832.","journal-title":"Cancer Res"},{"key":"2178_CR7","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.1038\/srep05811","volume":"4","author":"H Zhang","year":"2014","unstructured":"Zhang H, Qiu J, Ye C, Yang D, Gao L, Su Y, et al. ROR1 expression correlated with poor clinical outcome in human ovarian cancer. Sci Rep. 2014;4:5811. https:\/\/doi.org\/10.1038\/srep05811.","journal-title":"Sci Rep"},{"key":"2178_CR8","doi-asserted-by":"publisher","first-page":"17266","DOI":"10.1073\/pnas.1419599111","volume":"111","author":"S Zhang","year":"2014","unstructured":"Zhang S, Cui B, Lai H, Liu G, Ghia EM, Widhopf GF, et al. Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy. Proc Natl Acad Sci USA. 2014;111:17266\u201371. https:\/\/doi.org\/10.1073\/pnas.1419599111.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2178_CR9","doi-asserted-by":"publisher","first-page":"e0127092","DOI":"10.1371\/journal.pone.0127092","volume":"10","author":"Y Liu","year":"2015","unstructured":"Liu Y, Yang H, Chen T, Luo Y, Xu Z, Li Y, Yang J. Silencing of receptor tyrosine kinase ROR1 inhibits tumor-cell proliferation via PI3K\/AKT\/mTOR signaling pathway in lung adenocarcinoma. PLoS ONE. 2015;10:e0127092. https:\/\/doi.org\/10.1371\/journal.pone.0127092.","journal-title":"PLoS ONE"},{"key":"2178_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/cbf.3172","volume":"34","author":"E-H Jung","year":"2016","unstructured":"Jung E-H, Lee H-N, Han G-Y, Kim M-J, Kim C-W. Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells. Cell Biochem Funct. 2016;34:149\u201357. https:\/\/doi.org\/10.1002\/cbf.3172.","journal-title":"Cell Biochem Funct"},{"key":"2178_CR11","doi-asserted-by":"publisher","first-page":"12916","DOI":"10.1074\/jbc.M109.073924","volume":"285","author":"TM Wright","year":"2010","unstructured":"Wright TM, Rathmell WK. Identification of Ror2 as a hypoxia-inducible factor target in von Hippel-Lindau-associated renal cell carcinoma. J Biol Chem. 2010;285:12916\u201324. https:\/\/doi.org\/10.1074\/jbc.M109.073924.","journal-title":"J Biol Chem"},{"key":"2178_CR12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1172\/JCI83535","volume":"126","author":"J Yu","year":"2016","unstructured":"Yu J, Chen L, Cui B, Widhopf GF, Shen Z, Wu R, et al. Wnt5a induces ROR1\/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation. J Clin Invest. 2016;126:585\u201398. https:\/\/doi.org\/10.1172\/JCI83535.","journal-title":"J Clin Invest"},{"key":"2178_CR13","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1158\/2159-8290.CD-13-0005","volume":"3","author":"MP O\u2019Connell","year":"2013","unstructured":"O\u2019Connell MP, Marchbank K, Webster MR, Valiga AA, Kaur A, Vultur A, et al. Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2. Cancer Discov. 2013;3:1378\u201393. https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0005.","journal-title":"Cancer Discov"},{"key":"2178_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/1476-4598-9-170","volume":"9","author":"E Lara","year":"2010","unstructured":"Lara E, Calvanese V, Huidobro C, Fern\u00e1ndez AF, Moncada-Pazos A, Obaya AJ, et al. Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer. Mol Cancer. 2010;9:170. https:\/\/doi.org\/10.1186\/1476-4598-9-170.","journal-title":"Mol Cancer"},{"key":"2178_CR15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/s12885-016-2576-7","volume":"16","author":"SSQ Ma","year":"2016","unstructured":"Ma SSQ, Srivastava S, Llamosas E, Hawkins NJ, Hesson LB, Ward RL, Ford CE. ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration. BMC Cancer. 2016;16:508. https:\/\/doi.org\/10.1186\/s12885-016-2576-7.","journal-title":"BMC Cancer"},{"key":"2178_CR16","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3748\/wjg.v18.i12.1328","volume":"18","author":"M Geng","year":"2012","unstructured":"Geng M, Cao Y-C, Chen Y-J, Jiang H, Bi L-Q, Liu X-H. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. World J Gastroenterol. 2012;18:1328\u201338. https:\/\/doi.org\/10.3748\/wjg.v18.i12.1328.","journal-title":"World J Gastroenterol"},{"key":"2178_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/bpa.12017","volume":"23","author":"SE Lee","year":"2013","unstructured":"Lee SE, Lim SD, Kang SY, Suh SB, Suh Y-L. Prognostic significance of Ror2 and Wnt5a expression in medulloblastoma. Brain Pathol. 2013;23:445\u201353. https:\/\/doi.org\/10.1111\/bpa.12017.","journal-title":"Brain Pathol"},{"key":"2178_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ygyno.2018.01.025","volume":"148","author":"CE Henry","year":"2018","unstructured":"Henry CE, Llamosas E, Daniels B, Coopes A, Tang K, Ford CE. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer. Gynecol Oncol. 2018;148:576\u201384. https:\/\/doi.org\/10.1016\/j.ygyno.2018.01.025.","journal-title":"Gynecol Oncol"},{"key":"2178_CR19","doi-asserted-by":"publisher","first-page":"5958","DOI":"10.1038\/onc.2017.206","volume":"36","author":"K Roarty","year":"2017","unstructured":"Roarty K, Pfefferle AD, Creighton CJ, Perou CM, Rosen JM. Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression. Oncogene. 2017;36:5958\u201368. https:\/\/doi.org\/10.1038\/onc.2017.206.","journal-title":"Oncogene"},{"key":"2178_CR20","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.tcb.2008.08.006","volume":"18","author":"JL Green","year":"2008","unstructured":"Green JL, Kuntz SG, Sternberg PW. Ror receptor tyrosine kinases: orphans no more. Trends Cell Biol. 2008;18:536\u201344. https:\/\/doi.org\/10.1016\/j.tcb.2008.08.006.","journal-title":"Trends Cell Biol"},{"key":"2178_CR21","doi-asserted-by":"publisher","first-page":"26301","DOI":"10.1074\/jbc.M113.466086","volume":"288","author":"NR Rasmussen","year":"2013","unstructured":"Rasmussen NR, Wright TM, Brooks SA, Hacker KE, Debebe Z, Sendor AB, et al. Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of Wnt signaling in renal cancer. J Biol Chem. 2013;288:26301\u201310. https:\/\/doi.org\/10.1074\/jbc.M113.466086.","journal-title":"J Biol Chem"},{"key":"2178_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00432-014-1824-y","volume":"141","author":"C Henry","year":"2015","unstructured":"Henry C, Quadir A, Hawkins NJ, Jary E, Llamosas E, Kumar D, et al. Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both \u03b2-catenin dependent and independent Wnt signalling. J Cancer Res Clin Oncol. 2015;141:243\u201354. https:\/\/doi.org\/10.1007\/s00432-014-1824-y.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2178_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/gtc.12599","volume":"23","author":"T Saji","year":"2018","unstructured":"Saji T, Nishita M, Ogawa H, Doi T, Sakai Y, Maniwa Y, Minami Y. Critical role of the Ror-family of receptor tyrosine kinases in invasion and proliferation of malignant pleural mesothelioma cells. Genes Cells. 2018;23:606\u201313. https:\/\/doi.org\/10.1111\/gtc.12599.","journal-title":"Genes Cells"},{"key":"2178_CR24","doi-asserted-by":"publisher","first-page":"30562","DOI":"10.1074\/jbc.M115.697615","volume":"290","author":"S Martinez","year":"2015","unstructured":"Martinez S, Scerbo P, Giordano M, Daulat AM, Lhoumeau A-C, Thom\u00e9 V, et al. The PTK7 and ROR2 protein receptors interact in the vertebrate WNT\/planar cell polarity (PCP) pathway. J Biol Chem. 2015;290:30562\u201372. https:\/\/doi.org\/10.1074\/jbc.M115.697615.","journal-title":"J Biol Chem"},{"key":"2178_CR25","doi-asserted-by":"publisher","first-page":"13730","DOI":"10.1074\/jbc.M116.733766","volume":"291","author":"E-M Brinkmann","year":"2016","unstructured":"Brinkmann E-M, Mattes B, Kumar R, Hagemann AIH, Gradl D, Scholpp S, et al. Secreted frizzled-related protein 2 (sFRP2) redirects non-canonical Wnt signaling from Fz7 to Ror2 during vertebrate gastrulation. J Biol Chem. 2016;291:13730\u201342. https:\/\/doi.org\/10.1074\/jbc.M116.733766.","journal-title":"J Biol Chem"},{"key":"2178_CR26","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s00018-013-1485-z","volume":"71","author":"L Li","year":"2014","unstructured":"Li L, Ying J, Tong X, Zhong L, Su X, Xiang T, et al. Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting \u03b2-catenin and AKT signaling but frequently methylated in common carcinomas. Cell Mol Life Sci. 2014;71:2179\u201392. https:\/\/doi.org\/10.1007\/s00018-013-1485-z.","journal-title":"Cell Mol Life Sci"},{"key":"2178_CR27","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cell.2014.07.002","volume":"158","author":"R Ghosh","year":"2014","unstructured":"Ghosh R, Wang L, Wang ES, Perera BGK, Igbaria A, Morita S, et al. Allosteric inhibition of the IRE1\u03b1 RNase preserves cell viability and function during endoplasmic reticulum stress. Cell. 2014;158:534\u201348. https:\/\/doi.org\/10.1016\/j.cell.2014.07.002.","journal-title":"Cell"},{"key":"2178_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s004270100140","volume":"211","author":"R Al-Shawi","year":"2001","unstructured":"Al-Shawi R, Ashton SV, Underwood C, Simons JP. Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development. Dev Genes Evol. 2001;211:161\u201371.","journal-title":"Dev Genes Evol"},{"key":"2178_CR29","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/dvdy.22212","volume":"239","author":"M Yamada","year":"2010","unstructured":"Yamada M, Udagawa J, Matsumoto A, Hashimoto R, Hatta T, Nishita M, et al. Ror2 is required for midgut elongation during mouse development. Dev Dyn. 2010;239:941\u201353. https:\/\/doi.org\/10.1002\/dvdy.22212.","journal-title":"Dev Dyn"},{"key":"2178_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/humu.10233","volume":"22","author":"AR Afzal","year":"2003","unstructured":"Afzal AR, Jeffery S. One gene, two phenotypes: ROR2 mutations in autosomal recessive Robinow syndrome and autosomal dominant brachydactyly type B. Hum Mutat. 2003;22:1\u201311. https:\/\/doi.org\/10.1002\/humu.10233.","journal-title":"Hum Mutat"},{"key":"2178_CR31","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/78107","volume":"25","author":"AR Afzal","year":"2000","unstructured":"Afzal AR, Rajab A, Fenske CD, Oldridge M, Elanko N, Ternes-Pereira E, et al. Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2. Nat Genet. 2000;25:419\u201322. https:\/\/doi.org\/10.1038\/78107.","journal-title":"Nat Genet"},{"key":"2178_CR32","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1093\/hmg\/ddp345","volume":"18","author":"W Schwarzer","year":"2009","unstructured":"Schwarzer W, Witte F, Rajab A, Mundlos S, Stricker S. A gradient of ROR2 protein stability and membrane localization confers brachydactyly type B or Robinow syndrome phenotypes. Hum Mol Genet. 2009;18:4013\u201321. https:\/\/doi.org\/10.1093\/hmg\/ddp345.","journal-title":"Hum Mol Genet"},{"key":"2178_CR33","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.gene.2014.06.035","volume":"547","author":"D Huang","year":"2014","unstructured":"Huang D, Jiang S, Zhang Y, Liu X, Zhang J, He R. A new mutation in the gene ROR2 causes brachydactyly type B1. Gene. 2014;547:106\u201310. https:\/\/doi.org\/10.1016\/j.gene.2014.06.035.","journal-title":"Gene"},{"key":"2178_CR34","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12935-017-0482-y","volume":"17","author":"B Dai","year":"2017","unstructured":"Dai B, Yan T, Zhang A. ROR2 receptor promotes the migration of osteosarcoma cells in response to Wnt5a. Cancer Cell Int. 2017;17:112. https:\/\/doi.org\/10.1186\/s12935-017-0482-y.","journal-title":"Cancer Cell Int"},{"key":"2178_CR35","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1038\/oncsis.2016.32","volume":"5","author":"CE Henry","year":"2016","unstructured":"Henry CE, Llamosas E, Djordjevic A, Hacker NF, Ford CE. Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer. Oncogenesis. 2016;5:e226. https:\/\/doi.org\/10.1038\/oncsis.2016.32.","journal-title":"Oncogenesis"},{"key":"2178_CR36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tem.2009.01.003","volume":"20","author":"J Mandl","year":"2009","unstructured":"Mandl J, M\u00e9sz\u00e1ros T, B\u00e1nhegyi G, Hunyady L, Csala M. Endoplasmic reticulum: nutrient sensor in physiology and pathology. Trends Endocrinol Metab. 2009;20:194\u2013201. https:\/\/doi.org\/10.1016\/j.tem.2009.01.003.","journal-title":"Trends Endocrinol Metab"},{"key":"2178_CR37","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1517\/17460440903052559","volume":"4","author":"DC Hiss","year":"2009","unstructured":"Hiss DC, Gabriels GA. Implications of endoplasmic reticulum stress, the unfolded protein response and apoptosis for molecular cancer therapy. Part I: targeting p53, Mdm2, GADD153\/CHOP, GRP78\/BiP and heat shock proteins. Expert Opin Drug Discov. 2009;4:799\u2013821. https:\/\/doi.org\/10.1517\/17460440903052559.","journal-title":"Expert Opin Drug Discov"},{"key":"2178_CR38","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1210\/er.2007-0039","volume":"29","author":"D Scheuner","year":"2008","unstructured":"Scheuner D, Kaufman RJ. The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes. Endocr Rev. 2008;29:317\u201333. https:\/\/doi.org\/10.1210\/er.2007-0039.","journal-title":"Endocr Rev"},{"key":"2178_CR39","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/nrd2755","volume":"7","author":"I Kim","year":"2008","unstructured":"Kim I, Xu W, Reed JC. Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov. 2008;7:1013\u201330. https:\/\/doi.org\/10.1038\/nrd2755.","journal-title":"Nat Rev Drug Discov"},{"key":"2178_CR40","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cmet.2012.07.007","volume":"16","author":"AG Lerner","year":"2012","unstructured":"Lerner AG, Upton J-P, Praveen PVK, Ghosh R, Nakagawa Y, Igbaria A, et al. IRE1\u03b1 induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. Cell Metab. 2012;16:250\u201364. https:\/\/doi.org\/10.1016\/j.cmet.2012.07.007.","journal-title":"Cell Metab"},{"key":"2178_CR41","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1667\/RR14344.1","volume":"185","author":"F Li","year":"2016","unstructured":"Li F, Zheng X, Liu Y, Li P, Liu X, Ye F, et al. Different roles of CHOP and JNK in mediating radiation-induced autophagy and apoptosis in breast cancer cells. Radiat Res. 2016;185:539\u201348. https:\/\/doi.org\/10.1667\/RR14344.1.","journal-title":"Radiat Res"},{"key":"2178_CR42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ncb2738","volume":"15","author":"J Han","year":"2013","unstructured":"Han J, Back SH, Hur J, Lin Y-H, Gildersleeve R, Shan J, et al. ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat Cell Biol. 2013;15:481\u201390. https:\/\/doi.org\/10.1038\/ncb2738.","journal-title":"Nat Cell Biol"},{"key":"2178_CR43","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1128\/MCB.21.4.1249-1259.2001","volume":"21","author":"KD McCullough","year":"2001","unstructured":"McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ. Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol. 2001;21:1249\u201359. https:\/\/doi.org\/10.1128\/MCB.21.4.1249-1259.2001.","journal-title":"Mol Cell Biol"},{"key":"2178_CR44","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.cell.2007.04.027","volume":"129","author":"H Puthalakath","year":"2007","unstructured":"Puthalakath H, O\u2019Reilly LA, Gunn P, Lee L, Kelly PN, Huntington ND, et al. ER stress triggers apoptosis by activating BH3-only protein Bim. Cell. 2007;129:1337\u201349. https:\/\/doi.org\/10.1016\/j.cell.2007.04.027.","journal-title":"Cell"},{"key":"2178_CR45","doi-asserted-by":"publisher","first-page":"e39586","DOI":"10.1371\/journal.pone.0039586","volume":"7","author":"AP Ghosh","year":"2012","unstructured":"Ghosh AP, Klocke BJ, Ballestas ME, Roth KA. CHOP potentially co-operates with FOXO3a in neuronal cells to regulate PUMA and BIM expression in response to ER stress. PLoS ONE. 2012;7:e39586. https:\/\/doi.org\/10.1371\/journal.pone.0039586.","journal-title":"PLoS ONE"},{"key":"2178_CR46","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.nbd.2012.02.003","volume":"46","author":"KA Fernandes","year":"2012","unstructured":"Fernandes KA, Harder JM, Fornarola LB, Freeman RS, Clark AF, Pang I-H, et al. JNK2 and JNK3 are major regulators of axonal injury-induced retinal ganglion cell death. Neurobiol Dis. 2012;46:393\u2013401. https:\/\/doi.org\/10.1016\/j.nbd.2012.02.003.","journal-title":"Neurobiol Dis"},{"key":"2178_CR47","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1002\/jnr.20786","volume":"83","author":"Y Munemasa","year":"2006","unstructured":"Munemasa Y, Ohtani-Kaneko R, Kitaoka Y, Kumai T, Kitaoka Y, Hayashi Y, et al. Pro-apoptotic role of c-Jun in NMDA-induced neurotoxicity in the rat retina. J Neurosci Res. 2006;83:907\u201318. https:\/\/doi.org\/10.1002\/jnr.20786.","journal-title":"J Neurosci Res"},{"key":"2178_CR48","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1126\/science.287.5453.664","volume":"287","author":"F Urano","year":"2000","unstructured":"Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, Ron D. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science. 2000;287:664\u20136.","journal-title":"Science"},{"key":"2178_CR49","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.exer.2013.04.021","volume":"112","author":"KA Fernandes","year":"2013","unstructured":"Fernandes KA, Harder JM, Kim J, Libby RT. JUN regulates early transcriptional responses to axonal injury in retinal ganglion cells. Exp Eye Res. 2013;112:106\u201317. https:\/\/doi.org\/10.1016\/j.exer.2013.04.021.","journal-title":"Exp Eye Res"},{"key":"2178_CR50","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ejps.2011.10.009","volume":"44","author":"AP Lakshmanan","year":"2011","unstructured":"Lakshmanan AP, Thandavarayan RA, Palaniyandi SS, Sari FR, Meilei H, Giridharan VV, et al. Modulation of AT-1R\/CHOP-JNK-Caspase12 pathway by olmesartan treatment attenuates ER stress-induced renal apoptosis in streptozotocin-induced diabetic mice. Eur J Pharm Sci. 2011;44:627\u201334. https:\/\/doi.org\/10.1016\/j.ejps.2011.10.009.","journal-title":"Eur J Pharm Sci"},{"key":"2178_CR51","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1083\/jcb.200904060","volume":"186","author":"G Li","year":"2009","unstructured":"Li G, Mongillo M, Chin K-T, Harding H, Ron D, Marks AR, Tabas I. Role of ERO1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis. J Cell Biol. 2009;186:783\u201392. https:\/\/doi.org\/10.1083\/jcb.200904060.","journal-title":"J Cell Biol"},{"key":"2178_CR52","doi-asserted-by":"publisher","first-page":"11422","DOI":"10.1038\/ncomms11422","volume":"7","author":"Z Xu","year":"2016","unstructured":"Xu Z, Bu Y, Chitnis N, Koumenis C, Fuchs SY, Diehl JA. miR-216b regulation of c-Jun mediates GADD153\/CHOP-dependent apoptosis. Nat Commun. 2016;7:11422. https:\/\/doi.org\/10.1038\/ncomms11422.","journal-title":"Nat Commun"},{"key":"2178_CR53","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a035063","author":"DL Prole","year":"2019","unstructured":"Prole DL, Taylor CW. Structure and function of IP3 receptors. Cold Spring Harb Perspect Biol. 2019. https:\/\/doi.org\/10.1101\/cshperspect.a035063.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2178_CR54","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.ajpath.2012.03.005","volume":"180","author":"A Jain","year":"2012","unstructured":"Jain A, Olovsson M, Burton GJ, Yung H-W. Endothelin-1 induces endoplasmic reticulum stress by activating the PLC-IP(3) pathway: implications for placental pathophysiology in preeclampsia. Am J Pathol. 2012;180:2309\u201320. https:\/\/doi.org\/10.1016\/j.ajpath.2012.03.005.","journal-title":"Am J Pathol"},{"key":"2178_CR55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.toxlet.2019.02.009","volume":"306","author":"Y Takanezawa","year":"2019","unstructured":"Takanezawa Y, Nakamura R, Hamaguchi M, Yamamoto K, Sone Y, Uraguchi S, Kiyono M. Docosahexaenoic acid enhances methylmercury-induced endoplasmic reticulum stress and cell death and eicosapentaenoic acid potentially attenuates these effects in mouse embryonic fibroblasts. Toxicol Lett. 2019;306:35\u201342. https:\/\/doi.org\/10.1016\/j.toxlet.2019.02.009.","journal-title":"Toxicol Lett"},{"key":"2178_CR56","doi-asserted-by":"publisher","first-page":"252","DOI":"10.14348\/molcells.2019.2440","volume":"42","author":"J-I Shin","year":"2019","unstructured":"Shin J-I, Jeon Y-J, Lee S, Lee YG, Kim JB, Lee K. G-protein-coupled receptor 120 mediates DHA-induced apoptosis by regulating IP3R, ROS and ER stress levels in cisplatin-resistant cancer cells. Mol Cells. 2019;42:252\u201361. https:\/\/doi.org\/10.14348\/molcells.2019.2440.","journal-title":"Mol Cells"},{"key":"2178_CR57","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/abbs\/gmr079","volume":"43","author":"A De","year":"2011","unstructured":"De A. Wnt\/Ca2+ signaling pathway: a brief overview. Acta Biochim Biophys Sin. 2011;43:745\u201356. https:\/\/doi.org\/10.1093\/abbs\/gmr079.","journal-title":"Acta Biochim Biophys Sin"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-02178-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-02178-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-02178-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T00:17:19Z","timestamp":1608855439000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-02178-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2178"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-02178-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"14 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal experiment was approved by the Experimental Animal Ethics Committee of Qilu Hospital of Shandong University (Approval number: KYLL-2016-338).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"428"}}